Medartis Holding AGXSWX:MED +4.28%76 OCF Yield % is 3.78 as of Jun. 27, 2026, which is 121% above its 10-year median of 1.71. GuruFocus rates XSWX:MED with a GF Score™ of 76/100 and a GF Value™ of CHF105.66 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 852 Medical Devices & Instruments companies, Medartis Holding AG ranks better than 59.74% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
The historical rank and industry rank for Medartis Holding AG's OCF Yield % or its related term are showing as below:
XSWX:MED'
s OCF Yield % Range Over the Past 10 Years
Min: -0.51 Med: 1.71 Max: 4.48
Current: 3.78
During the past 12 years, the highest OCF Yield % of Medartis Holding AG was 4.48%. The lowest was -0.51%. And the median was 1.71%.
XSWX:MED's OCF Yield % is ranked better than 59.74% of 852
companies
in the Medical Devices & Instruments industry
Industry Median: 1.785
vs XSWX:MED: 3.78
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Medartis Holding AG OCF Yield % Related Terms
Medartis Holding AG OCF Yield % Historical Data
* Premium members only.
The historical data trend for Medartis Holding AG's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Medartis Holding AG's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medartis Holding AG OCF Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Medartis Holding AG's OCF Yield % distribution charts can be found below:
* The bar in red indicates where Medartis Holding AG's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medartis Holding AG (XSWX:MED) has a OCF Yield % of 3.78 as of Jun. 27, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Medartis Holding AG and its competitors. This is 121% above median its historical median of 1.71. According to the industry distribution chart, Medartis Holding AG ranks #343 out of 852 companies in the Medical Devices & Instruments industry, placing it in the top 40.3%.
Is Medartis Holding AG's OCF Yield % too high?
Medartis Holding AG's current OCF Yield % of 3.78 is 121% above median its 10-year median of 1.71. The Medical Devices & Instruments industry median OCF Yield % is 1.79. Medartis Holding AG's value of 3.78 is 111.8% above this industry median. Based on the distribution chart, Medartis Holding AG ranks #343 out of 852 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Medartis Holding AG has a GF Score™ of 76/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medartis Holding AG's OCF Yield % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Medartis Holding AG ranks #343 out of 852 companies for OCF Yield %. This puts Medartis Holding AG in the upper half of its industry. The industry median OCF Yield % is 1.79. Medartis Holding AG's value of 3.78 is 111.8% above this benchmark. While the company's 10-year median is 1.71 vs. the industry median of 1.79, Medartis Holding AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Medical Devices & Instruments company?
The median OCF Yield % among Medical Devices & Instruments companies is 1.79, based on 852 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medartis Holding AG's current OCF Yield % of 3.78 is 111.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Medartis Holding AG and its competitors. For the Medical Devices & Instruments industry, the median OCF Yield % is 1.79 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medartis Holding AG's current OCF Yield % is 3.78, which is 121% above median its own 10-year median of 1.71. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medartis Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Medartis Holding AG (XSWX:MED) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF105.66, compared to a current price of CHF80.40 — trading 23.9% below its estimated fair value. The current OCF Yield % is 3.78, which is 121% above median its 10-year median of 1.71 and 111.8% above the Medical Devices & Instruments industry median of 1.79. Medartis Holding AG's overall GF Score™ is 76/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Medartis Holding AG (XSWX:MED), the current OCF Yield % is 3.78 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medartis Holding AG (XSWX:MED) Overvalued in 2026?
Based on GuruFocus' analysis, Medartis Holding AG stock appears to be undervalued.
The current stock price of CHF80.40 is trading 23.9% below its estimated GF Value™ of CHF105.66.
GuruFocus considers Medartis Holding AG to be Modestly Undervalued.
Key valuation signals for XSWX:MED:
OCF Yield %: 3.78 (121% above median its 10-year median of 1.71)
GF Value™: CHF105.66 vs. price of CHF80.40 (23.9% below fair value)
Industry Position: 111.8% above the Medical Devices & Instruments median (#343 of 852)
No single metric tells the full story. See the XSWX:MED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medartis Holding AG is a medical device company. The company's product profile is divided into APTUS products, StealthFix Products, and MODUS products. APTUS includes products for the Hand, Wrist, Elbow, Shoulder, and Foot. MODUS comprises products for the mandible. Geographically, it derives the majority of its revenue from Europe, Middle East and Africa (EMEA) and also has a presence in North America, Asia Pacific, and Latin America.
76GF Score
Get the complete analysis for XSWX:MED
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:MED has been successfully added to your 
